Our research benefits our patients
Based on our research, we initiate clinical trials aimed to prevent or eliminate cancer. Our trials combine the best standard of care with novel therapies, including immunotherapy and intra-operative imaging. Our studies shape clinical best practices to directly benefit our patients.
By studying gynaecological cancer in the laboratory,
we uncover new features of cancer cells that can be targeted for therapy or early detection.
we accelerate drug discovery by creating laboratory models of cancer that better capture the complexity of a human tumour;
we develop our results as new therapies for patients or as diagnostics for early detection.